Researchers Argue for “Embryoid” Ethics Revamp

Scientists issue a call to reconsider the rules governing the creation of tissues, organs, and other structures made possible by recent advances in synthetic biology.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

An eight-cell human embryo, three days after fertilizationWIKIMEDIA, EKEM: RWJMS IVF PROGRAMGiven advances in synthetic biology, researchers can now use stem cells to create human tissues, organs, and other approximations of early developmental structures. These recent innovations also raise ethical questions that may not be adequately answered by the self-imposed 14-day rule that has governed research on embryos for decades. That rule prohibits experiments using embryos older than two weeks post-fertilization, and resulted from the facts that researchers could only keep embryos alive for 14 days in the lab and that, after 14 days, embryos begin to develop the rudiments of a nervous system.

Now, Harvard scientists who pioneered some of the advances that allow for the creation of what they’ve dubbed synthetic human entities with embryo-like features (SHEEFs), are calling for a rethink of the 14-day rule. Embryoids are balls of pluripotent stem cells that begin to resemble embryos.

“Here we argue that these and related experiments raise more foundational issues that cannot be fixed by adjusting the 14-day rule, because the framework underlying the rule cannot adequately describe the ways by which synthetic human entities with embryo-like features (SHEEFs) might develop morally concerning features through altered forms of development,” the researchers wrote in an article published in eLife yesterday (March 21). “We propose that limits on research with SHEEFs be based as directly as possible on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio